Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00079443
Status:
TERMINATED
Last Update Posted:
2013-07-01
First Post:
2004-03-08
Brief Title:
FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkins Lymphoma
Sponsor:
Organization:
National Cancer Institute NCI